The main objective of this study is to evaluate the safety, effectiveness and tolerability of three concentrations of A-101 25%, 32.5%, and 40%, when applied to individual seborrheic keratosis target lesions on the back compared with a matching A-101 vehicle.
Evaluate the safety, tolerability of A-101 when applied to seborrheic keratosis lesions on the back of subjects.